Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT06627231
PHASE1
Mass Balance Clinical Trial With TEV-56286
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
View on ClinicalTrials.gov
Summary
Mass balance clinical trial with TEV-56286
Official title: A Phase 1 Open-Label Mass Balance Clinical Trial to Investigate the Absorption, Metabolism, and Excretion of Single Oral Administration of [14C]-TEV-56286 Following Multiple Oral Administrations of Nonlabeled TEV-56286 to Healthy Male Participants
Key Details
Gender
MALE
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
8
Start Date
2024-10-08
Completion Date
2024-11-29
Last Updated
2026-08-07
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
TEV-56286
Oral capsule
DRUG
[14C]-TEV-56286
Oral capsule
Locations (1)
Teva Investigational Site 38189
Groningen, Netherlands